Publication | Closed Access

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis

Zoledronic AcidBone HealthOsteoarthritisBone TurnoverOsteoporosisBone DensityMedicineSecondary OsteoporosisOrthopaedic SurgeryBone Metabolism